Skip to main content
Clinical Trials/NCT01131520
NCT01131520
Completed
Not Applicable

SBIRT in New Mexico

Friends Research Institute, Inc.1 site in 1 country360 target enrollmentJune 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Drug Abuse
Sponsor
Friends Research Institute, Inc.
Enrollment
360
Locations
1
Primary Endpoint
Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to compare the effectiveness in reducing drug use and its associated problems of a brief intervention for drug use delivered by a behavioral health counselor as compared to a brief intervention delivered by a computerized intervention.

Detailed Description

Drug use is a significant cause of morbidity and mortality in the United States. Efforts to develop and rigorously evaluate methods to provide Screening, Brief Intervention and Referral to Treatment (SBIRT) for drug users are needed. Computerized screening and brief interventions in particular have the potential to circumvent some of the potential problems of integrating SBIRT delivered by a counselor into busy primary care settings. These interventions may reduce drug use among individuals who are using drugs but are not yet drug dependent.

Registry
clinicaltrials.gov
Start Date
June 2010
End Date
July 2015
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 years or older
  • Moderate risk category on the ASSIST scores

Exclusion Criteria

  • planning to move out of New Mexico in the next year
  • receipt of formal drug abuse treatment or a brief intervention for drug use in the past month.

Outcomes

Primary Outcomes

Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score

Time Frame: 3 months post-baseline

The ASSIST's Global Continuum of Illicit Drug Risk was used. A higher score is considered more severe risk. The scores range from 0 to 308.

Hair Testing

Time Frame: 3 month post-baseline

The number of participants testing positive on Radioimmunoassay (RIA) Hair Testing for opiates, cocaine, amphetamine and tetrahydrocannabinol (THC)

Secondary Outcomes

  • Human Immunodeficiency Virus (HIV) Drug Use Risk Assessment Battery Subscale(3 months post-baseline)
  • Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score(12 months post-baseline)
  • Hair Testing(12 month post-baseline)
  • Human Immunodeficiency Virus (HIV) Risk Assessment Battery Subscale(6 month post-baseline)
  • Human Immunodeficiency Virus (HIV) Risk Assessment Battery Subscale Score(12 month post-baseline)

Study Sites (1)

Loading locations...

Similar Trials